Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1166 ARTÍCULOS , VIENDO DEL 616 AL 630

Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study

Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Cederholm T, Palmblad J.

J Alzheimers Dis. 2015;48(3):805-12. doi: 10.3233/JAD-150102.

Structural Neuroimaging of the Medial Temporal Lobe in Alzheimer's Disease Clinical Trials

Menéndez-González M, de Celis Alonso B, Salas-Pacheco J, Arias-Carrión O.

J Alzheimers Dis. 2015;48(3):581-9. doi: 10.3233/JAD-150226.

Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS)

Matsuzono K, Sato K, Kono S, Hishikawa N, Ohta Y, Yamashita T, Deguchi K, Nakano Y, Abe K.

J Alzheimers Dis. 2015;48(3):757-63. doi: 10.3233/JAD-150518.

New Perspectives on Alzheimer's Disease and Nutrition

Gustafson DR, Clare Morris M, Scarmeas N, Shah RC, Sijben J, Yaffe K, Zhu X.

J Alzheimers Dis. 2015;46(4):1111-27. doi: 10.3233/JAD-150084.

Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease

Liu-Seifert H, Siemers E, Price K, Han B, Selzler KJ, Henley D, Sundell K, Aisen P, Cummings J, Raskin J, Mohs R; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2015;47(1):205-14. doi: 10.3233/JAD-142508.

Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease

Bukhari SN, Jantan I.

Mini Rev Med Chem. 2015;15(13):1110-21. doi: 10.2174/138955751513150923101841.

Stress, Meditation, and Alzheimer's Disease Prevention: Where The Evidence Stands

Khalsa DS.

J Alzheimers Dis. 2015;48(1):1-12. doi: 10.3233/JAD-142766.

Alzheimer's disease: a report from the 7th Kuopio Alzheimer symposium

Haapasalo A, Pikkarainen M, Soininen H.

Neurodegener Dis Manag. 2015 Oct;5(5):379-82. doi: 10.2217/nmt.15.31. Epub 2015 Oct 19.

Attitudes of Research Participants and the General Public Regarding Disclosure of Alzheimer Disease Research Results

Gooblar J, Roe CM, Selsor NJ, Gabel MJ, Morris JC.

JAMA Neurol. 2015 Dec;72(12):1484-90. doi: 10.1001/jamaneurol.2015.2875.

Socio-economic Aspects of Alzheimer's Disease

Marešová P, Mohelská H, Dolejš J, Kuča K.

Curr Alzheimer Res. 2015;12(9):903-11. doi: 10.2174/156720501209151019111448.

Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses

Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown RG, Banerjee S, Adams J, Johnson T, Bentham P, Phillips PP.

Lancet Neurol. 2015 Dec;14(12):1171-81. doi: 10.1016/S1474-4422(15)00258-6. Epub 2015 Oct 27.

[A comparison of the efficacy and safety of memantal and original memantine in the treatment of mild and moderate dementia in Alzheimer's disease]

Shiryaev OY, Shapovalov DL, Polozova TM, Goncharova OV, Kuznetsova NA, Cherenkova EV, Fedorova EY.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):56-61. doi: 10.17116/jnevro201511510156-61.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias